As the population ages and survival from ischemic heart disease improves, the incidence and prevalence of congestive cardiac failure has increased dramatically. Medical treatments including ACE inhibitors, ß blockers, and aldosterone antagonists have improved the outlook for most patients. However, despite optimal medical treatment there is a significant group of patients who continue to suffer poor morbidity and mortality. Device based treatment consisting of implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) devices offer new modes of treatment to patients with symptomatic heart failure despite optimal medical therapy. ICDs have been shown to reduce mortality in patients with severe heart failure while CRT leads to an improvement in functional class, quality of life scores, physiological measures such as peak VO2, and reduce hospitalizations.
This CVI In-Person dinner program is FREE to attend and DOES NOT offer CME/CEU Credits.
Live and In-Person Only – No Virtual Option Available
*Space is Limited- Registration is Required
*Registrants are required to upload proof of vaccination with registration. You will receive an email with the link to the form.
*Although not required, guests are welcome to wear masks when not actively eating, drinking or speaking from the podium.